Epsilon M&A Deal Report - Spirig Healthcare
Transaction Multiples for the Valuation of Private Companies
STADA Arzneimittel / Spirig Healthcare
No EMAT :
62850
Announced Date :
19/05/2011
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
STADA Arzneimittel
Target :
Spirig Healthcare
Country :
Switzerland
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 2011, Spirig HealthCare is the f ormer generics division of Swiss SMEs Spirig Pharma AG . It is a pharmaceutical company providing generic and brand products . > Provides an in-house...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ||||||||
| Current | 
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 03/02/2014 | Private Group led by IDI | Winncare | France | * | 62374 |
| 11/09/2013 | L'Oreal | NICKEL (Interparfums Men Cosmetic Business) | France | ** | 62301 |
Source: Epsilon Research / EMAT
